Generic pharmaceuticals company Padagis announced on Tuesday a new partnership with The Naloxone Project (TNP), a clinician-led, nonprofit organisation dedicated to transforming the response to the opioid crisis.

The collaboration is aimed at expanding access across the United States to generic naloxone nasal spray, providing access to a lower-cost naloxone product and TNP's expertise and tailored support.

Dr Don Stader, founder of The Naloxone Project, said: "This partnership represents a unique opportunity for the states we work with. By combining Padagis' trusted naloxone spray with our medical expertise, we're able to deliver more than a medication -- we're providing enhanced resources, support, and custom solutions to strengthen state programmes that save lives."